Keyphrases
Antibody Response
100%
Titre
100%
Pneumocystis
100%
Asthma Severity
100%
Pediatric Asthma
100%
Severe Asthma
83%
Pediatric Patients
50%
Asthma
50%
Cystic Fibrosis
50%
Moderate-to-severe Asthma
50%
Pneumocystis Jirovecii
33%
Chronic Obstructive Pulmonary Disease
33%
High Risk
16%
Genetic Factors
16%
Environmental Factors
16%
HIV Patients
16%
Clinical Course
16%
Respiratory Disease
16%
Treatment Course
16%
Multiple Chronic Conditions
16%
Chronic Lung Disease
16%
Tetanus Toxoid
16%
Protective Antibodies
16%
Asthma Symptoms
16%
Total IgE
16%
Infection Symptoms
16%
Symptom Exacerbation
16%
Respiratory Microbiome
16%
Airway Colonization
16%
Naturally Occurring Antibodies
16%
Pneumocystis Infection
16%
Kexin
16%
Medicine and Dentistry
Pediatrics
100%
Antibody Response
100%
Asthma
100%
Severe Asthma
62%
Pediatrics Patient
37%
Cystic Fibrosis
25%
Chronic Obstructive Pulmonary Disease
25%
Human Immunodeficiency Virus
12%
Pneumocystis Pneumonia
12%
Cross Sectional Study
12%
Immunoglobulin E
12%
Chronic Lung Disease
12%
Disease Course
12%
Patient with Asthma
12%
Respiratory Disease
12%
Environmental Factor
12%
Microbiome
12%
Patient with Cystic Fibrosis
12%
Tetanus Toxoid
12%
Pneumocystosis
12%
Pneumocystis Jirovecii
12%
Kexin
12%
Immunology and Microbiology
Antibody Response
100%
Asthma
100%
Pneumocystis
100%
Severe Asthma
55%
Human Immunodeficiency Virus
11%
Blood Plasma
11%
Immunoglobulin E
11%
Microbiome
11%
Tetanus Vaccine
11%
Pneumocystis Jiroveci
11%
Immunology
11%